Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Antioxidants (Basel) ; 12(10)2023 Oct 23.
Article in English | MEDLINE | ID: mdl-37891973

ABSTRACT

Inflammation and oxidative stress are essential components in a myriad of pathogenic entities that lead to metabolic and chronic diseases. Moreover, inflammation in its different phases is necessary for the initiation and maintenance of a healthy pregnancy. Therefore, an equilibrium between a necessary/pathologic level of inflammation and oxidative stress during pregnancy is needed to avoid disease development. High-density lipoproteins (HDL) are important for a healthy pregnancy and a good neonatal outcome. Their role in fetal development during challenging situations is vital for maintaining the equilibrium. However, in certain conditions, such as obesity, diabetes, and other cardiovascular diseases, it has been observed that HDL loses its protective properties, becoming dysfunctional. Bioactive compounds have been widely studied as mediators of inflammation and oxidative stress in different diseases, but their mechanisms of action are still unknown. Nonetheless, these agents, which are obtained from functional foods, increase the concentration of HDL, TRC, and antioxidant activity. Therefore, this review first summarizes several mechanisms of HDL participation in the equilibrium between inflammation and oxidative stress. Second, it gives an insight into how HDL may act as a vector for bioactive compounds. Third, it describes the relationships between the inflammation process in pregnancy and HDL activity. Consequently, different databases were used, including MEDLINE, PubMed, and Scopus, where scientific articles published in the English language up to 2023 were identified.

2.
Life (Basel) ; 12(10)2022 Oct 20.
Article in English | MEDLINE | ID: mdl-36295088

ABSTRACT

Multisystem inflammatory syndrome in children (MIS-C) has been widely reported in some children diagnosed with SARS-CoV-2. Clinical signs of MIS-C are manifested at 2 to 4 weeks after SARS-CoV-2 infection, where elevated biomarkers of inflammation and cardiac dysfunction are the hallmark of this syndrome when infection or exposure to SARS-CoV-2 has been confirmed. However, after two years of acknowledgment, MIS-C treatment is still under research to reach safety and effectiveness in the acute phase in children. Therefore, in this review, we discuss the potential use of natural compounds with antioxidant and anti-inflammatory effects to reduce collateral damage caused by hyperinflammation in MIS-C pathology for new research in treatment and interventions.

3.
Int J Mol Sci ; 23(10)2022 May 17.
Article in English | MEDLINE | ID: mdl-35628408

ABSTRACT

Human immunodeficiency virus (HIV) infection has continued to be the subject of study since its discovery nearly 40 years ago. Significant advances in research and intake of antiretroviral therapy (ART) have slowed the progression and appearance of the disease symptoms and the incidence of concomitant diseases, which are the leading cause of death in HIV+ persons. However, the prolongation of ART is closely related to chronic degenerative diseases and pathologies caused by oxidative stress (OS) and alterations in lipid metabolism (increased cholesterol levels), both of which are conditions of ART. Therefore, recent research focuses on using natural therapies to diminish the effects of ART and HIV infection: regulating lipid metabolism and reducing OS status. The present review summarizes current information on OS and cholesterol metabolism in HIV+ persons and how the consumption of certain phytochemicals can modulate these. For this purpose, MEDLINE and SCOPUS databases were consulted to identify publications investigating HIV disease and natural therapies and their associated effects.


Subject(s)
HIV Infections , Antioxidants/metabolism , Antioxidants/pharmacology , Antioxidants/therapeutic use , Cholesterol , Gene Expression , HIV Infections/complications , Humans , Lipid Metabolism , Phytochemicals/metabolism , Phytochemicals/pharmacology , Phytochemicals/therapeutic use
4.
Foods ; 11(9)2022 Apr 25.
Article in English | MEDLINE | ID: mdl-35563955

ABSTRACT

Obesity is a disease characterized by an inflammatory process in the adipose tissue due to diverse infiltrated immune cells, an increased secretion of proinflammatory molecules, and a decreased secretion of anti-inflammatory molecules. On the other hand, obesity increases the risk of several diseases, such as cardiovascular diseases, diabetes, and cancer. Their treatment is based on nutritional and pharmacological strategies. However, natural products are currently implemented as complementary and alternative medicine (CAM). Polyphenols and fiber are naturally compounds with potential action to reduce inflammation through several pathways and play an important role in the prevention and treatment of obesity, as well as in other non-communicable diseases. Hence, this review focuses on the recent evidence of the molecular mechanisms of polyphenols and dietary fiber, from Scopus, Science Direct, and PubMed, among others, by using key words and based on recent in vitro and in vivo studies.

5.
Metab Syndr Relat Disord ; 20(5): 264-272, 2022 06.
Article in English | MEDLINE | ID: mdl-35325577

ABSTRACT

Background: Metabolic syndrome (MetS) has increased worldwide, and since 2012, prevalence of obesity, hypertension, diabetes, and dyslipidemia has increased in Mexico. Objective: To assess the prevalence of MetS, and its relationship with sociodemographic and lifestyle factors among Mexican adults. Methods: Analytical cross-sectional study nationally representative, carried out on Mexican adults (≥20-year-old adults of both sexes; n = 4595). Socioeconomic factors, geographic area, health care coverage and previous medical diagnoses of diabetes and hypertension, and smoking were assessed. Anthropometrics, and triglyceride, total cholesterol, high-density lipoprotein cholesterol (HDL-chol), creatinine, and glucose plasma levels were measured. The ATP III MetS definition was applied. Results: A MetS prevalence of 44.2% was observed, which was higher in males than females, and increased with age, lower school level, and overweight. Hyperglycemia, hypertriglyceridemia, low HDL-chol, abdominal obesity, and hypertension were higher in people with MetS, and were associated with obesity. Conclusions: The prevalence of MetS in the Mexican adult observed in the ENSADER 2007 was high, and mainly in men than women. Specific associations of MetS with age, scholar level, and body mass index have been found. Obesity and MetS were associated.


Subject(s)
Hypertension , Metabolic Syndrome , Adult , Cholesterol, HDL , Cross-Sectional Studies , Female , Humans , Hypertension/complications , Male , Metabolic Syndrome/diagnosis , Metabolic Syndrome/epidemiology , Mexico/epidemiology , Obesity/complications , Obesity/epidemiology , Prevalence , Risk Factors , Young Adult
6.
J. negat. no posit. results ; 6(9): 1196-1208, Sept. 2021. tab, graf
Article in Spanish | IBECS | ID: ibc-223366

ABSTRACT

El término sexualidad hace referencia al grupo de convenciones, roles y conductas asociadas a la cultura y que suponen expresiones del deseo sexual, emociones disímiles, relación de poder, mediadas por el sistema de creencias, valores, actitudes, sentimientos y otros puntos referentes a la postura en la sociedad, por ejemplo la raza, grupo étnico y condición social(1). La percepción de las personas sobre la sexualidad del adulto mayor, ha creado un efecto de tipo emocional y conductual gracias a mitos, prejuicios, ideologías y actitudes que pueden ocasionar un inadecuado ejercicio de la sexualidad en dicha edad. Objetivo: Este trabajo fue determinar el nivel de prejuicio de adultos jóvenes de 18 a 35 años, respecto a la sexualidad durante la vejez. Material y Métodos: Se utilizó un diseño transversal-descriptivo, ya que la investigación se realizó en un período de tiempo específico y las variables no fueron modificadas, sino observadas. Se aplicó un muestreo no probabilístico por disposición de 100 adultos jóvenes de 18 a 35 años de edad en el estado de Hidalgo, México. El instrumento utilizado fue el ‘’Cuestionario de actitudes hacia la sexualidad en la vejez (CASV2020)’’, aplicado de manera presencial y con una duración de entre 5 a 10 minutos por participante. El cuestionario categorizaba en estereotipos las variables. Se obtuvo el consentimiento informado de los participantes. Los datos obtenidos fueron analizados en un paquete estadístico SPSS V.21, calculándose medidas de frecuencia y tendencia central. Resultados: La población estudiada consistió en un 28% al género masculino y un 72% al género femenino, al categorizar los datos obtenidos, se logró obtener que 6 ítems se encontraron en un nivel bajo de estereotipo, mientras que 4 ítems correspondieron a un nivel medio y 3 ítems a un nivel muy alto de estereotipo...(AU)


The term sexuality refers to the group of conventions, roles and behaviors associated with culture and that involve expressions of sexual desire, dissimilar emotions, power relationship, mediated by the belief system, values, attitudes, feelings and other points of reference. to position in society, such as race, ethnic group and social status(1). The perception of people about the sexuality of the elderly has created an emotional and behavioral effect thanks to myths, prejudices, ideologies and attitudes that can cause an inappropriate exercise of sexuality at that age. Objective: This work was to determine the level of prejudice of young adults between 18 and 35 years old, regarding sexuality during old age. Material and Methods: A cross-sectional-descriptive design was used, since the research was carried out in a specific period of time and the variables were not modified, but observed. A non-probability sampling was applied by disposition of 100 young adults between 18 and 35 years of age in the state of Hidalgo, Mexico. The instrument used was the '' Questionnaire of attitudes towards sexuality in old age (CASV2020)'', applied in person and with a duration of between 5 to 10 minutes per participant. The questionnaire categorized the variables into stereotypes. Informed consent was obtained from the participants. The data obtained were analyzed in a statistical package SPSS V.21, calculating measures of frequency and central tendency. Results: The studied population consisted of 28% male and 72% female, when categorizing the data obtained, it was possible to obtain that 6 items were found at a low level of stereotype, while 4 items corresponded to a level medium and 3 items at a very high level of stereotype. Conclusion: When questioning about the sexuality of the elderly, the participants answered in the central values, that is, neutral, which means that the sample studied presented a low level of prejudice towards the sexuality of the elderly.(AU)


Subject(s)
Humans , Male , Female , Young Adult , Sexuality , Prejudice , Sexism , Gender Expression , Aging , Sexual Behavior , Cross-Sectional Studies , Epidemiology, Descriptive , Mexico
7.
Molecules ; 25(14)2020 Jul 21.
Article in English | MEDLINE | ID: mdl-32708063

ABSTRACT

Previous studies demonstrated that pomegranate, which is a source of several bioactive molecules, induces modifications of high-density lipoproteins (HDL) lipid composition and functionality. However, it remains unclear whether the beneficial effects of pomegranate are related to improvement in the lipid components of HDL. Therefore, in this placebo-controlled study, we characterized the size and lipid composition of HDL subclasses and assessed the functionality of these lipoproteins after 30 days of supplementation with a pomegranate microencapsulated (MiPo) in New Zealand white rabbits. We observed a significant decrease in plasma cholesterol, triglycerides, and non-HDL sphingomyelin, as well as increases in HDL cholesterol and HDL phospholipids after supplementation with MiPo. Concomitantly, the triglycerides of the five HDL subclasses isolated by electrophoresis significantly decreased, whereas phospholipids, cholesterol, and sphingomyelin of HDL subclasses, as well as the HDL size distribution remained unchanged. Of particular interest, the triglycerides content of HDL, estimated by the triglycerides-to-phospholipids ratio, decreased significantly after MiPo supplementation. The modification on the lipid content after the supplementation was associated with an increased resistance of HDL to oxidation as determined by the conjugated dienes formation catalyzed by Cu2+. Accordingly, paraoxonase-1 (PON1) activity determined with phenylacetate as substrate increased after MiPo. The effect of HDL on endothelial function was analyzed by the response to increasing doses of acetylcholine of aorta rings co-incubated with the lipoproteins in an isolated organ bath. The HDL from rabbits that received placebo partially inhibited the endothelium-dependent vasodilation. In contrast, the negative effect of HDL on endothelial function was reverted by MiPo supplementation. These results show that the beneficial effects of pomegranate are mediated at least in part by improving the functionality of HDL, probably via the reduction of the content of triglycerides in these lipoproteins.


Subject(s)
Cardiotonic Agents/chemistry , Fruit/chemistry , Lipoproteins, HDL/metabolism , Plant Extracts/chemistry , Pomegranate/chemistry , Animals , Aryldialkylphosphatase/metabolism , Cardiotonic Agents/pharmacology , Cholesterol/metabolism , Copper/metabolism , Drug Carriers/chemistry , Endothelium/metabolism , Fruit/metabolism , Glucose/chemistry , Humans , Male , Phospholipids/metabolism , Plant Extracts/pharmacology , Polysaccharides/chemistry , Pomegranate/metabolism , Rabbits , Triglycerides/metabolism , Vasodilation/drug effects
8.
Nutrients ; 11(8)2019 Jul 25.
Article in English | MEDLINE | ID: mdl-31349559

ABSTRACT

(1) Background: the composition of high-density lipoproteins (HDL) becomes altered during the postprandial state, probably affecting their functionality vis-à-vis the endothelium. Since acute coronary syndrome (ACS) in women is frequently associated with endothelial dysfunction, it is likely that HDL are unable to improve artery vasodilation in these patients. Therefore, we characterized HDL from women with ACS in fasting and postprandial conditions. We also determined whether microencapsulated pomegranate (MiPo) reverts the HDL abnormalities, since previous studies have suggested that this fruit improves HDL functionality. (2) Methods: Eleven women with a history of ACS were supplemented daily with 20 g of MiPo, for 30 days. Plasma samples were obtained during fasting and at different times, after a lipid load test to determine the lipid profile and paraoxonase-1 (PON1) activity. HDL were isolated by sequential ultracentrifugation to determine their size distribution and to assess their effect on endothelial function, by using an in vitro model of rat aorta rings. (3) Results: MiPo improved the lipid profile and increased PON1 activity, as previously reported, with fresh pomegranate juice. After supplementation with MiPo, the incremental area under the curve of triglycerides decreased to half of the initial values. The HDL distribution shifted from large HDL to intermediate and small-size particles during the postprandial period in the basal conditions, whereas such a shift was no longer observed after MiPo supplementation. Consistently, HDL isolated from postprandial plasma samples hindered the vasodilation of aorta rings, and this endothelial dysfunction was reverted after MiPo consumption. (4) Conclusions: MiPo exhibited the same beneficial effects on the lipid profile and PON1 activity as the previously reported fresh pomegranate. In addition, MiPo supplementation reverted the negative effects of HDL on endothelial function generated during the postprandial period in women with ACS.


Subject(s)
Acute Coronary Syndrome/drug therapy , Endothelium, Vascular/drug effects , Hypertriglyceridemia/drug therapy , Hypolipidemic Agents/administration & dosage , Lipoproteins, HDL/blood , Plant Extracts/administration & dosage , Pomegranate , Postprandial Period , Triglycerides/blood , Vasodilation/drug effects , Acute Coronary Syndrome/blood , Acute Coronary Syndrome/diagnosis , Administration, Oral , Adult , Animals , Aryldialkylphosphatase/blood , Biomarkers/blood , Endothelium, Vascular/metabolism , Endothelium, Vascular/physiopathology , Female , Fruit , Humans , Hypertriglyceridemia/blood , Hypertriglyceridemia/diagnosis , Hypolipidemic Agents/adverse effects , Middle Aged , Plant Extracts/adverse effects , Rats, Wistar , Time Factors , Treatment Outcome
9.
Molecules ; 23(11)2018 Oct 23.
Article in English | MEDLINE | ID: mdl-30360466

ABSTRACT

High-density lipoproteins (HDL) comprise a heterogeneous family of lipoprotein particles divided into subclasses that are determined by density, size and surface charge as well as protein composition. Epidemiological studies have suggested an inverse correlation between High-density lipoprotein-cholesterol (HDL-C) levels and the risk of cardiovascular diseases and atherosclerosis. HDLs promote reverse cholesterol transport (RCT) and have several atheroprotective functions such as anti-inflammation, anti-thrombosis, and anti-oxidation. HDLs are considered to be atheroprotective because they are associated in serum with paraoxonases (PONs) which protect HDL from oxidation. Polyphenol consumption reduces the risk of chronic diseases in humans. Polyphenols increase the binding of HDL to PON1, increasing the catalytic activity of PON1. This review summarizes the evidence currently available regarding pharmacological and alternative treatments aimed at improving the functionality of HDL-C. Information on the effectiveness of the treatments has contributed to the understanding of the molecular mechanisms that regulate plasma levels of HDL-C, thereby promoting the development of more effective treatment of cardiovascular diseases. For that purpose, Scopus and Medline databases were searched to identify the publications investigating the impact of current therapies focused on high-density lipoproteins.


Subject(s)
Cardiovascular Diseases/drug therapy , Cardiovascular Diseases/metabolism , Hypolipidemic Agents/therapeutic use , Lipoproteins, HDL/metabolism , Animals , Biomarkers , Cardiovascular Diseases/etiology , Cholesterol, HDL/blood , Cholesterol, HDL/metabolism , Endothelial Cells/drug effects , Endothelial Cells/metabolism , Humans , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Hypolipidemic Agents/pharmacology , Lipid Metabolism/drug effects , Lipoproteins/classification , Lipoproteins/metabolism , Lipoproteins, HDL/blood , Oxidation-Reduction/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...